Communicable Disease

Communicable Disease

Communicable and Infectious diseases kill one in three people worldwide; in developing regions, they are responsible for over half of all deaths. Finding ways to prevent, treat and cure them will have a profound impact on health worldwide.

Key Initiatives

Grand Challenges in Global Health

Funded by the Gates Foundation, Grand Challenges in Global Health encompasses 43 project across 33 countries, working toward scientific breakthroughs to prevent, treat, and cure diseases that kill millions each year.

Key Initiatives

MAL-ED: A Global Network for the Study of Malnutrition and Enteric Diseases

Poor nutrition is linked to more than half of all child deaths worldwide. This initiative, funded by the Gates Foundation, draws together an international group of scientific investigators to study the inter-relationship between enteric infections and malnutrition to reduce its devastating effects.

Key Initiatives

CTC-VIMC: Supporting the Development of a Vaccine for HIV/AIDS

The Foundation for NIH is one of 19 consortia comprising the Collaboration for AIDS Vaccine Discovery. Funded by the Gates Foundation, this initiative is aimed toward developing an effective AIDS vaccine.

Program

HIT-TB: Identification of High-quality HITs for Tuberculosis

The new HIT_TB project is another Foundation and the National Institute of Allergy and Infectious Diseases, along with Pfizer Inc., and academic institutions in the United Kingdom and South Africa. Its focus is on combating tuberculosis, which infects one-third of the world’s population.

Program

Vector-based Control of Transmission: Discovery Research (VCTR)

VCTR logoThe “Vector-based Control of Transmission: Discovery Research” program is an extension of the Grand Challenges in Global Health initiative, aimed at establishing a pipeline of innovative new tools that will be safe, easily deployed, effective and sustainable for u

Program

Centralized Envelope Comparative Immunogenicity Study (CECI)

This project aims to address a fundamental problem blocking the development of a successful HIV-1 vaccine. The goal is to understand how best to design T cell immunogens to address the broad genetic diversity of HIV-1.

Program

Path Youth Program HIV/AIDS in Adolescents

Improving the health and well being of HIV-positive and at-risk youth is the goal of the Physical/Psychosocial Advocacy & Treatment For HIV Youth Program (PATH). This multi-disciplinary collaboration of experienced HIV researchers and care providers was established by Children’s Memorial Hospital and Howard Brown Community Health Center to conduct research on the north side of Chicago.

Program

Human Papilloma Virus Clinical Trial

Human papilloma virus (HPV) is the primary cause of cervical cancer. With more than $6 million in support from the Foundation for NIH, investigators have expanded the scope of an existing National Cancer Institute (NCI) Phase III clinical trial examining a vaccine intended to prevent cervical and other cancers caused by this virus. The expansion makes possible validation, regulatory support and quality-assurance monitoring of the vaccine. The goal is to ensure that the resulting discoveries can be quickly translated into therapies that will prevent the spread of HPV.

Related News
Aneesh Chopra Joins 2010 mHealth Summit as Keynote Speaker
2010 mHealth Summit Attracts Leaders in Wireless Health Research and Technology

Related Events
The Fourteenth Annual Norman P. Salzman Memorial Award and Symposium in Virology
November 30-30, 2012